Skip to main content

Table 1 Baseline characteristics

From: Relationship between serum soluble suppression of tumorigenicity (ST) 2 and global longitudinal strain in early onset preeclampsia

Variables

Total n = 30

Age (years)*

30.83 ± 7.09

Gestational age (weeks)**

31 (30–32)

Parity, n (%)

 

 Primipara

13 (43.3)

 Multipara

17 (56.7)

BMI, kg/m2

 

 Before pregnancy*

21.2 (20.58–21.63)

 Present state*

28.85 (26.2-29.35)

Weight gain during pregnancy*

9.77 ± 1.43

Blood pressure (mmHg)**

 

 Systolic

155 (147–160)

 Diastolic

90 (90–100)

Echocardiography parameters

 

 LVMI, g/m2*

112.91 ± 24.78

 LAVI, mL/m2*

23.39 ± 4.72

 LVEF, %*

60.13 ± 6.56

 Diastolic dysfunction

20 (66.7)

  Normal

10 (33.33%)

  Grade I

20 (66.67%)

Metildopa 500 mg, n(%)

sST2 (ng/mL)

GLS (%)

30 (100)

145.75 (37.5–297.5)

-17.4 (-13,3 – (-20,1))

  1. BMI: Body mass index, LAVI: Left atrial volume index, LVEF : Left ventricular ejection fraction, LVMI : Left ventricular mass index, sST2: soluble suppression of tumorigenicity-2, GLS: Global longitudinal strain, SD: standard deviation
  2. *Data was shown as mean (±SD)
  3. **Data was shown as median (minimum-maximum)